{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T17:29:54Z","timestamp":1762018194687},"reference-count":34,"publisher":"Japan Neurosurgical Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol. Med. Chir.(Tokyo)"],"published-print":{"date-parts":[[2019]]},"DOI":"10.2176\/nmc.oa.2019-0040","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T22:06:42Z","timestamp":1561068402000},"page":"331-336","source":"Crossref","is-referenced-by-count":3,"title":["Predictive Factors of Antiparkinsonian Drug Reduction after Subthalamic Stimulation for Parkinson\u2019s Disease"],"prefix":"10.2176","volume":"59","author":[{"given":"Kazuhiro","family":"SAMURA","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"MIYAGI","sequence":"additional","affiliation":[{"name":"Department of Stereotactic and Functional Neurosurgery, Fukuoka Mirai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minako","family":"KAWAGUCHI","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"YOSHIDA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Kyushu University"},{"name":"Department of Anatomy and Physiology, Faculty of Medicine, Saga University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"OKAMOTO","sequence":"additional","affiliation":[{"name":"Faculty of Arts and Science, Kyushu University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatou","family":"KAWASHIMA","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, International University of Health and Welfare, School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"971","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Benabid AL, Chabardes S, Mitrofanis J, Pollak P: Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson\u2019s disease. <i>Lancet Neurol<\/i> 8: 67\u201381, 2009","DOI":"10.1016\/S1474-4422(08)70291-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Benabid AL, Pollak P, Gross C, et al.: Acute and long-term effects of subthalamic nucleus stimulation in Parkinson\u2019s disease. <i>Stereotact Funct Neurosurg<\/i> 62: 76\u201384, 1994","DOI":"10.1159\/000098600"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Krack P, Batir A, Van Blercom N, et al.: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. <i>N Engl J Med<\/i> 349: 1925\u20131934, 2003","DOI":"10.1056\/NEJMoa035275"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Limousin P, Pollak P, Benazzouz A, et al.: Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. <i>Lancet<\/i> 345: 91\u201395, 1995","DOI":"10.1016\/S0140-6736(95)90062-4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ferrara J, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J: Impact of STN-DBS on life and health satisfaction in patients with Parkinson\u2019s disease. <i>J Neurol Neurosurg Psychiatry<\/i> 81: 315\u2013319, 2010","DOI":"10.1136\/jnnp.2009.184127"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Limousin P, Krack P, Pollak P, et al.: Electrical stimulation of the subthalamic nucleus in advanced Parkinson\u2019s disease. <i>N Engl J Med<\/i> 339: 1105\u20131111, 1998","DOI":"10.1056\/NEJM199810153391603"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Siderowf A, Jaggi JL, Xie SX, et al.: Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson\u2019s disease. <i>Mov Disord<\/i> 21: 746\u2013753, 2006","DOI":"10.1002\/mds.20786"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Follett KA, Weaver FM, Stern M, et al.: Pallidal versus subthalamic deep-brain stimulation for Parkinson\u2019s disease. <i>N Engl J Med<\/i> 362: 2077\u20132091, 2010","DOI":"10.1056\/NEJMoa0907083"},{"key":"9","unstructured":"9) Odekerken VJ, van Laar T, Staal MJ, et al.: Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson\u2019s disease (NSTAPS study): a randomised controlled trial. <i>Lancet Neurol<\/i> 12: 37\u201344, 2013"},{"key":"10","unstructured":"10) Weaver FM, Follett KA, Stern M, et al.: Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. <i>Neurology<\/i> 79: 55\u201365, 2012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Katayama Y, Kasai M, Oshima H, Fukaya C, Yamamoto T, Mizutani T: Double blinded evaluation of the effects of pallidal and subthalamic nucleus stimulation on daytime activity in advanced Parkinson\u2019s disease. <i>Parkinsonism Relat Disord<\/i> 7: 35\u201340, 2000","DOI":"10.1016\/S1353-8020(00)00046-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Weaver F, Follett K, Hur K, Ippolito D, Stern M: Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. <i>J Neurosurg<\/i> 103: 956\u2013967, 2005","DOI":"10.3171\/jns.2005.103.6.0956"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Callesen MB, Scheel-Kr\u00fcger J, Kringelbach ML, M\u00f8ller A: A systematic review of impulse control disorders in Parkinson\u2019s disease. <i>J Parkinsons Dis<\/i> 3: 105\u2013138, 2013","DOI":"10.3233\/JPD-120165"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Papapetropoulos S, Mash DC: Psychotic symptoms in Parkinson\u2019s disease. From description to etiology. <i>J Neurol<\/i> 252: 753\u2013764, 2005","DOI":"10.1007\/s00415-005-0918-5"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yoshida F, Miyagi Y, Kishimoto J, et al.: Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson\u2019s disease patients. <i>Stereotact Funct Neurosurg<\/i> 87: 45\u201349, 2009","DOI":"10.1159\/000195719"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. <i>Mov Disord<\/i> 25: 2649\u20132653, 2010","DOI":"10.1002\/mds.23429"},{"key":"17","unstructured":"17) Witjas T, Kaphan E, Azulay JP, et al.: Nonmotor fluctuations in Parkinson\u2019s disease: frequent and disabling. <i>Neurology<\/i> 59: 408\u2013413, 2002"},{"key":"18","unstructured":"18) Kleiner-Fisman G, Herzog J, Fisman DN, et al.: Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. <i>Mov Disord<\/i> 21: S290\u2013S304, 2006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Merola A, Rizzi L, Zibetti M, et al.: Medical therapy and subthalamic deep brain stimulation in advanced Parkinson\u2019s disease: a different long-term outcome? <i>J Neurol Neurosurg Psychiatry<\/i> 85: 552\u2013559, 2014","DOI":"10.1136\/jnnp-2013-305271"},{"key":"20","unstructured":"20) Ortega-Cubero S, Clavero P, Irurzun C, et al.: Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson\u2019s disease: two-year\u2019 follow-up. <i>Parkinsonism Relat Disord<\/i> 19: 543\u2013547, 2013"},{"key":"21","unstructured":"21) Zibetti M, Pesare M, Cinquepalmi A, et al.: Antiparkinsonian therapy modifications in PD patients after STN DBS: a retrospective observational analysis. <i>Parkinsonism Relat Disord<\/i> 14: 608\u2013612, 2008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Daniels C, Krack P, Volkmann J, et al.: Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson\u2019s disease. <i>Mov Disord<\/i> 25: 1583\u20131589, 2010","DOI":"10.1002\/mds.23078"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) De Gaspari D, Siri C, Landi A, et al.: Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson\u2019s disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus. <i>J Neurol Neurosurg Psychiatry<\/i> 77: 450\u2013453, 2006","DOI":"10.1136\/jnnp.2005.078659"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Funkiewiez A, Ardouin C, Krack P, et al.: Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson\u2019s disease. <i>Mov Disord<\/i> 18: 524\u2013530, 2003","DOI":"10.1002\/mds.10441"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Saint-Cyr JA, Tr\u00e9panier LL, Kumar R, Lozano AM, Lang AE: Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson\u2019s disease. <i>Brain<\/i> 123: 2091\u20132108, 2000","DOI":"10.1093\/brain\/123.10.2091"},{"key":"26","unstructured":"26) Smeding HM, Speelman JD, Koning-Haanstra M, et al.: Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. <i>Neurology<\/i> 66: 1830\u20131836, 2006"},{"key":"27","unstructured":"27) Witt K, Daniels C, Reiff J, et al.: Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson\u2019s disease: a randomised, multicentre study. <i>Lancet Neurol<\/i> 7: 605\u2013614, 2008"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK: Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. <i>Parkinsonism Relat Disord<\/i> 17: 321\u2013327, 2011","DOI":"10.1016\/j.parkreldis.2011.01.011"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Dafsari HS, Reddy P, Herchenbach C, et al.: Beneficial effects of bilateral subthalamic stimulation on non-motor symptoms in Parkinson\u2019s disease. <i>Brain Stimul<\/i> 9: 78\u201385, 2016","DOI":"10.1016\/j.brs.2015.08.005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Umemura A, Oka Y, Okita K, Matsukawa N, Yamada K: Subthalamic nucleus stimulation for Parkinson disease with severe medication-induced hallucinations or delusions. <i>J Neurosurg<\/i> 114: 1701\u20131705, 2011","DOI":"10.3171\/2011.2.JNS101261"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Stowe R, Ives N, Clarke CE, et al.: Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson\u2019s disease. <i>Mov Disord<\/i> 26: 587\u2013598, 2011","DOI":"10.1002\/mds.23517"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Oyama G, Foote KD, Jacobson CE, et al.: GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson\u2019s disease. <i>Parkinsonism Relat Disord<\/i> 18: 814\u2013818, 2012","DOI":"10.1016\/j.parkreldis.2012.03.022"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Durif F, Lemaire JJ, Debilly B, Dordain G: Long-term follow-up of globus pallidus chronic stimulation in advanced Parkinson\u2019s disease. <i>Mov Disord<\/i> 17: 803\u2013807, 2002","DOI":"10.1002\/mds.10128"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Katayama Y, Oshima H, Kano T, Kobayashi K, Fukaya C, Yamamoto T: Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson\u2019s disease. <i>Stereotact Funct Neurosurg<\/i> 84: 176\u2013179, 2006","DOI":"10.1159\/000094957"}],"container-title":["Neurologia medico-chirurgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/59\/9\/59_oa.2019-0040\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T10:37:53Z","timestamp":1663756673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/nmc\/59\/9\/59_oa.2019-0040\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2176\/nmc.oa.2019-0040","relation":{},"ISSN":["0470-8105","1349-8029"],"issn-type":[{"value":"0470-8105","type":"print"},{"value":"1349-8029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}